- Treatment with IFN- α2b was associated with reduced levels of IL-6 and CRP.

- Viral clearance was also correlated with a reduction in inflammatory markers.


Effects of IFN-α2b on inflammatory markers and how it compares to Arbidol treatment in COVID-19 positive patients

 - Overall, results showed that IFN- α2b was associated with accelerated viral clearance. 

- The IFN- α2b only treatment group had a mean time to viral clearance of 21.1 days.

- The Arbidol (ARB) only treatment group had a mean time to viral clearance of 27.9 days. 

- The IFN- α2b and ARB treatment group had a mean time to viral clearance of 20.3 days.


 Effects of IFN-α2b on viral clearance and how it compares to Arbidol treatment in COVID-19 positive patients

- Effects of IFN-α2b on viral clearance
- Effects of IFN-α2b on inflammatory markers 

University of Michigan - Ann Arbor

Interferon-α2b is a broad spectrum anti-virals responsible for having direct inhibitory effects on viral replication. In addition, IFN-α2b promotes an immune response in order to clear a viral infection.

- Findings in support 
- Finding opposed 

Learn Before

Related

Learn After